Compugen Seeks to Assuage Investors' Concerns over Cash Position | GenomeWeb
NEW YORK (GenomeWeb News) – Compugen today issued a statement in reaction to investors’ questions regarding the firm’s cash position and ability to fund its operations going forward, saying that it has sufficient cash on hand and marketable securities to run its business “well into 2010.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.